Somebody on Investor's Village just brought up the horrifying prospect of Culpepper being named CEO. Talk about a nightmarish scenario. While he's a genuinely nice guy by all indications, his lack of business savvy and ability to close a deal to date should eliminate him as a candidate. No doubt Alfred Smith will be playing a out-sized role in that decision making. It will be interesting to see how the CEO search topic is addressed on Thursday. Oh, and here's a stroll down memory lane. I'm sure we all recall the furor over the "as an example" use of $4B as a buyout figure. Well, back then that would have meant a little under $16/share. Now if the all warrants in total of 330M shares is accurate, the revised number would be just over $12/share. Dilution destroys wealth as well as PV-10 ablates tumors. Just sayin.....- Bruce
(0)
(0)
Provectus Biopharmaceuticals Inc. (PVCT) Stock Research Links